Cited by 8,897SARS-CoV-2 and COVID-19 ResearchAdvanced Electron Microscopy Techniques and ApplicationsAnimal Virus Infections Studies

The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.

Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation

Open access

Wrapp, Daniel, Wang, Nianshuang, Corbett, Kizzmekia S., Goldsmith, Jory A., Hsieh, Ching-Lin, Abiona, Olubukola, Graham, Barney S., McLellan, Jason S.·2020·Science

DOI 10.1126/science.abb2507PMC PMC7164637

Published version of a preprint

Open this paper in CoChat — free account Open PDF

Abstract

The outbreak of a novel coronavirus (2019-nCoV) represents a pandemic threat that has been declared a public health emergency of international concern. The CoV spike (S) glycoprotein is a key target for vaccines, therapeutic antibodies, and diagnostics. To facilitate medical countermeasure development, we determined a 3.5-angstrom-resolution cryo–electron microscopy structure of the 2019-nCoV S trimer in the prefusion conformation. The predominant state of the trimer has one of the three receptor-binding domains (RBDs) rotated up in a receptor-accessible conformation. We also provide biophysical and structural evidence that the 2019-nCoV S protein binds angiotensin-converting enzyme 2 (ACE2) with higher affinity than does severe acute respiratory syndrome (SARS)-CoV S. Additionally, we tested several published SARS-CoV RBD-specific monoclonal antibodies and found that they do not have appreciable binding to 2019-nCoV S, suggesting that antibody cross-reactivity may be limited between the two RBDs. The structure of 2019-nCoV S should enable the rapid development and evaluation of medical countermeasures to address the ongoing public health crisis.

Integrity signals

Registry

Crossref · 10.1126/science.abb2507

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

The text we found for this paper looks like another document, so its claims and self-check weren’t run. The registry and citation checks still apply.

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The text we found for this paper looks like another document, so the self-check wasn’t run.

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
UCSF Chimera—A visualization system for exploratory research and analysis
Pettersen, E. F., Goddard, T. D., Huang, C. C., Couch, G. S., Greenblatt, D. M., Meng, E. C., & Ferrin, T. E. (2004) · Journal of Computational Chemistry · doi:10.1002/jcc.20084 · Cited by 45,882
Coot : model-building tools for molecular graphics
Emsley, P., & Cowtan, K. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444904019158 · Cited by 30,571
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., Huang, C.-L., et al. (2020) · Nature · doi:10.1038/s41586-020-2012-7 · Cited by 21,969
Epidemiological and clinical characteristics of 99 cases of 2019 novel Coronavirus pneumonia in Wuhan, China: a descriptive study.
Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30211-7 · Cited by 21,415
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286
Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia
Li, Q., Guan, X., Wu, P., Wang, X., Zhou, L., Tong, Y., Ren, R., Leung, K. S. M., Lau, E. H. Y., Wong, J. Y., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001316 · Cited by 16,575
Comparative Protein Modelling by Satisfaction of Spatial Restraints
Šali, A., & Blundell, T. L. (1993) · Journal of Molecular Biology · doi:10.1006/jmbi.1993.1626 · Cited by 12,977
Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding
Lu, R., Zhao, X., Li, J., Niu, P., Yang, B., Wu, H., Wang, W., Song, H., Huang, B., Zhu, N., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30251-8 · Cited by 11,907
A new coronavirus associated with human respiratory disease in China
Wu, F., Zhao, S., Yu, B., Chen, Y.-M., Wang, W., Song, Z.-G., Hu, Y., Tao, Z.-W., Tian, J.-H., Pei, Y.-Y., et al. (2020) · Nature · doi:10.1038/s41586-020-2008-3 · Cited by 11,688

Flagged first, then by citations

Show all 42 references

Research works printed but not linked: 1

M. Hoffmann H. Kleine-Weber N. Krüger M. Müller C. Drosten S. Pöhlmann The novel coronavirus 2019 (2019-nCoV) uses the SARS-coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells. bioRxiv 929042 [Preprint]. 31 January 2020. https://doi.org/10.1101/2020.01.31.929042. · DOI

Sorted by citations

Items 501–600 of 1,048

Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants
Cai, Y., Zhang, J., Xiao, T., Lavine, C. L., Rawson, S., Peng, H., Zhu, H., Anand, K., Tong, P., Gautam, A. K., et al. (2021) · Science · doi:10.1126/science.abi9745 · Cited by 222
Coronavirus disease 2019 (COVID-19) in children and/or adolescents: a meta-analysis
Mantovani, A., Rinaldi, E., Zusi, C., Beatrice, G., Saccomani, M. D., & Dalbeni, A. (2020) · Pediatric Research · doi:10.1038/s41390-020-1015-2 · Cited by 218
Changes in SARS-CoV-2 Spike versus Nucleoprotein Antibody Responses Impact the Estimates of Infections in Population-Based Seroprevalence Studies
Fenwick, C. W., Croxatto, A., Coste, A. T., Pojer, F., André, C., Pellaton, C., Farina, A., Campos, J., Hacker, D. L., Lau, K., et al. (2020) · Journal of Virology · doi:10.1128/jvi.01828-20 · Cited by 226
COVID-19: A Call for Physical Scientists and Engineers
Huang, H., Fan, C., Li, M., Nie, H.-L., Wang, F.-B., Wang, H., Wang, R., Xia, J., Zheng, X., Zuo, X., et al. (2020) · ACS Nano · doi:10.1021/acsnano.0c02618 · Cited by 217
The SARS-CoV-2 monoclonal antibody combination, AZD7442, is protective in nonhuman primates and has an extended half-life in humans
Loo, Y., McTamney, P. M., Arends, R. H., Gasser, R. A., Abram, M. E., Cheng, L., Diallo, S., Flores, D. J., Bond, N. J., Ren, K., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abl8124 · Cited by 221
COVID-19 vaccine update: vaccine effectiveness, SARS-CoV-2 variants, boosters, adverse effects, and immune correlates of protection
Chi, W.-Y., Li, Y.-D., Huang, H., Chan, T. E. H., Chow, S.-Y., Su, J.-H., Ferrall, L., Hung, C., & Wu, T. ‐. (2022) · Journal of Biomedical Science · doi:10.1186/s12929-022-00853-8 · Cited by 225
SARS-CoV-2 requires cholesterol for viral entry and pathological syncytia formation
Sanders, D. W., Jumper, C. C., Ackerman, P. J., Bracha, D., Donlic, A., Kim, H., Kenney, D., Castello-Serrano, I., Suzuki, S., Tamura, T., et al. (2021) · eLife · doi:10.7554/elife.65962 · Cited by 224
Structural features of coronavirus SARS-CoV-2 spike protein: Targets for vaccination
Sternberg, A., & Naujokat, C. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118056 · Cited by 223
Outcome of SARS-CoV-2 infection is linked to MAIT cell activation and cytotoxicity
Flament, H., Rouland, M., Beaudoin, L., Toubal, A., Bertrand, L., Lebourgeois, S., Rousseau, C., Soulard, P., Gouda, Z., Cagninacci, L., et al. (2021) · Nature Immunology · doi:10.1038/s41590-021-00870-z · Cited by 219
Neurological Manifestations of COVID-19 (SARS-CoV-2): A Review
Ahmed, M. U., Hanif, M., Ali, M. J., Haider, M. A., Kherani, D., Memon, G. M., Karim, A. H., & Sattar, A. (2020) · Frontiers in Neurology · doi:10.3389/fneur.2020.00518 · Cited by 218
Increasing host cellular receptor—angiotensin‐converting enzyme 2 expression by coronavirus may facilitate 2019‐nCoV (or SARS‐CoV‐2) infection
Zhuang, M., Cheng, Y., Zhang, J., Jiang, X., Wang, L., Deng, J., & Wang, P. (2020) · Journal of Medical Virology · doi:10.1002/jmv.26139 · Cited by 215
Beyond neutralization: Fc-dependent antibody effector functions in SARS-CoV-2 infection
Zhang, A., Stacey, H. D., D’Agostino, M. R., Tugg, Y., Marzok, A., & Miller, M. S. (2022) · Nature reviews. Immunology · doi:10.1038/s41577-022-00813-1 · Cited by 225
DC/L-SIGN recognition of spike glycoprotein promotes SARS-CoV-2 trans-infection and can be inhibited by a glycomimetic antagonist
Thépaut, M., Luczkowiak, J., Vivès, C., Labiod, N., Bally, I., Lasala, F., Grimoire, Y., Fenel, D., Sattin, S., Thielens, N. M., et al. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009576 · Cited by 222
Overview of SARS-CoV-2 genome-encoded proteins
Bai, C., Zhong, Q., & Gao, G. F. (2021) · Science China Life Sciences · doi:10.1007/s11427-021-1964-4 · Cited by 227
Waves and variants of SARS-CoV-2: understanding the causes and effect of the COVID-19 catastrophe
Thakur, V., Bhola, S., Thakur, P., Patel, S. K. S., Kulshrestha, S., Ratho, R. K., & Kumar, P. (2022) · Infection · doi:10.1007/s15010-021-01734-2 · Cited by 195
“The S2 subunit is composed of a fusion peptide (FP), heptapeptide domains 1 and 2 (HPD1, HPD2), transmembrane domain (TM), and cytoplasm domain (CD) and is involved in membrane fusion [14].”
Background
Hyperglycemia, hydroxychloroquine, and the COVID‐19 pandemic
Brufsky, A. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25887 · Cited by 214
COVID-19-associated gastrointestinal and liver injury: clinical features and potential mechanisms
Zhong, P., Xu, J., Yang, D., Shen, Y. L., Wang, L., Feng, Y., Du, C., Song, Y., Wu, C., Hu, X., et al. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00373-7 · Cited by 209
The correlation between viral clearance and biochemical outcomes of 94 COVID-19 infected discharged patients
Yuan, J., Zou, R., Zeng, L., Kou, S., Lan, J., Li, X., Liang, Y., Ding, X., Tan, G., Tang, S., et al. (2020) · Inflammation Research · doi:10.1007/s00011-020-01342-0 · Cited by 209
Nanoparticle-Based Strategies to Combat COVID-19
Medhi, R., Srinoi, P., Ngo, N. M., Tran, H.-V., & Lee, T. R. (2020) · ACS Applied Nano Materials · doi:10.1021/acsanm.0c01978 · Cited by 208
Catechin and curcumin interact with S protein of SARS-CoV2 and ACE2 of human cell membrane: insights from computational studies
Jena, A. B., Kanungo, N., Nayak, V., Chainy, G. B. N., & Dandapat, J. (2021) · Scientific Reports · doi:10.1038/s41598-021-81462-7 · Cited by 208
Repurposing Therapeutics for COVID-19: Supercomputer-Based Docking to the SARS-CoV-2 Viral Spike Protein and Viral Spike Protein-Human ACE2 InterfacePreprint
Smith, M. D., & Smith, J. C. (2020) · ChemRxiv · doi:10.26434/chemrxiv.11871402.v4 · Cited by 217
Comprehensive mapping of mutations to the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human serum antibodies
Greaney, A. J., Loes, A. N., Crawford, K. H. D., Starr, T. N., Malone, K. D., Chu, H. Y., & Bloom, J. D. (2021) · doi:10.1101/2020.12.31.425021 · Cited by 1,178
“Two views of the RBD are shown: the surface of the RBD that is buried in the “down” conformation, and the surface that is always exposed and accessible (Walls et al., 2020; Wrapp et al., 2020).”
Background
The SARS-CoV-2 Spike variant D614G favors an open conformational state
Mansbach, R. A., Chakraborty, S., Nguyen, K., Montefiori, D. C., Korber, B., & Gnanakaran, S. (2021) · Science Advances · doi:10.1126/sciadv.abf3671 · Cited by 206
A critical overview of computational approaches employed for COVID-19 drug discovery
Muratov, E. N., Amaro, R., Andrade, C. H., Brown, N., Ekins, S., Fourches, D., Isayev, O., Kozakov, D., Medina-Franco, J. L., Merz, K. M., et al. (2021) · Chemical Society Reviews · doi:10.1039/d0cs01065k · Cited by 206
Receptome profiling identifies KREMEN1 and ASGR1 as alternative functional receptors of SARS-CoV-2
Gu, Y., Cao, J., Zhang, X., Gao, H., Wang, Y., Wang, J., He, J., Jiang, X., Zhang, J., Shen, G., et al. (2021) · Cell Research · doi:10.1038/s41422-021-00595-6 · Cited by 215
mRNA-1273 or mRNA-Omicron boost in vaccinated macaques elicits similar B cell expansion, neutralizing responses, and protection from Omicron
Gagné, M., Moliva, J. I., Foulds, K. E., Andrew, S. F., Flynn, B. J., Werner, A. P., Wagner, D. A., Teng, I., Lin, B. C., Moore, C. A., et al. (2022) · Cell · doi:10.1016/j.cell.2022.03.038 · Cited by 209
Self-citation
How does SARS-CoV-2 cause COVID-19?
Matheson, N. J., & Lehner, P. J. (2020) · Science · doi:10.1126/science.abc6156 · Cited by 205
Can Bioactive Lipids Inactivate Coronavirus (COVID-19)?
Das, U. N. (2020) · Archives of Medical Research · doi:10.1016/j.arcmed.2020.03.004 · Cited by 204
T‐cell responses and therapies against SARS‐CoV‐2 infection
Toor, S. M., Saleh, R., Nair, V. S., Taha, R. Z., & Elkord, E. (2020) · Immunology · doi:10.1111/imm.13262 · Cited by 208
The ACE2 expression in Sertoli cells and germ cells may cause male reproductive disorder after SARS‐CoV‐2 infection
Shen, Q., Xiao, X., Aierken, A., Yue, W., Wu, X., Liao, M., & Hua, J. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15541 · Cited by 206
Structural Characterization of SARS-CoV-2: Where We Are, and Where We Need to Be
Mariano, G., Farthing, R. J., Lale-Farjat, S. L. M., & Bergeron, J. R. C. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.605236 · Cited by 219
No evidence for basigin/CD147 as a direct SARS-CoV-2 spike binding receptor
Shilts, J., Crozier, T. W. M., Greenwood, E. J. D., Lehner, P. J., & Wright, G. J. (2021) · Scientific Reports · doi:10.1038/s41598-020-80464-1 · Cited by 209
RCSB Protein Data Bank: Celebrating 50 years of the PDB with new tools for understanding and visualizing biological macromolecules in 3D
Burley, S. K., Bhikadiya, C., Bi, C., Bittrich, S., Chen, L., Crichlow, G. V., Duarte, J. M., Dutta, S., Fayazi, M., Feng, Z., et al. (2021) · Protein Science · doi:10.1002/pro.4213 · Cited by 210
Structure of SARS-CoV-2 membrane protein essential for virus assembly
Zhang, Z., Nomura, N., Muramoto, Y., Ekimoto, T., Uemura, T., Liu, K., Yui, M., Kono, N., Aoki, J., Ikeguchi, M., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-32019-3 · Cited by 231
A Novel Reverse Transcription Loop-Mediated Isothermal Amplification Method for Rapid Detection of SARS-CoV-2
Lu, R., Wu, X., Wan, Z., Li, Y., Jin, X., & Zhang, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21082826 · Cited by 202
A Replication-Competent Vesicular Stomatitis Virus for Studies of SARS-CoV-2 Spike-Mediated Cell Entry and Its Inhibition
Dieterle, M. E., Haslwanter, D., Bortz, R. H., Wirchnianski, A. S., Lasso, G., Vergnolle, O., Abbasi, S. A., Fels, J. M., Laudermilch, E., Florez, C., et al. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2020.06.020 · Cited by 206
A Snapshot of the Global Race for Vaccines Targeting SARS-CoV-2 and the COVID-19 Pandemic
Funk, C. D., Laferrière, C. A., & Ardakani, A. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00937 · Cited by 204
Human ACE2-Functionalized Gold “Virus-Trap” Nanostructures for Accurate Capture of SARS-CoV-2 and Single-Virus SERS Detection
Yang, Y. P., Peng, Y., Lin, C., Li, L., Hu, J., He, J., Zeng, H., Huang, Z., Li, Z., Tanemura, M., et al. (2021) · Nano-Micro Letters · doi:10.1007/s40820-021-00620-8 · Cited by 199
ACE2 binding is an ancestral and evolvable trait of sarbecoviruses
Starr, T. N., Zepeda, S. K., Walls, A. C., Greaney, A. J., Alkhovsky, S. V., Veesler, D., & Bloom, J. D. (2022) · Nature · doi:10.1038/s41586-022-04464-z · Cited by 207
Morphology, Genome Organization, Replication, and Pathogenesis of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
Kumar, S., Nyodu, R., Maurya, V. K., & Saxena, S. K. (2020) · Medical virology · doi:10.1007/978-981-15-4814-7_3 · Cited by 198
Cytokine storm syndrome in coronavirus disease 2019: A narrative review
Gao, Y.-M., Xu, G., Wang, B., & Liu, B. (2020) · Journal of Internal Medicine · doi:10.1111/joim.13144 · Cited by 204
Extremely potent human monoclonal antibodies from COVID-19 convalescent patients
Andreano, E., Nicastri, E., Paciello, I., Pileri, P., Manganaro, N., Piccini, G., Manenti, A., Pantano, E., Kabanova, A., Troisi, M., et al. (2021) · Cell · doi:10.1016/j.cell.2021.02.035 · Cited by 199
ORF3a of SARS-CoV-2 promotes lysosomal exocytosis-mediated viral egress
Chen, D., Zheng, Q., Sun, L., Ji, M.-M., Li, Y., Deng, H., & Zhang, H. (2021) · Developmental Cell · doi:10.1016/j.devcel.2021.10.006 · Cited by 210
Structural Diversity of the SARS-CoV-2 Omicron Spike
Gobeil, S., Henderson, R. C., Stalls, V., Janowska, K., Huang, X., May, A. J., Speakman, M., Beaudoin, E. L., Manne, K., Li, D., et al. (2022) · Molecular Cell · doi:10.1016/j.molcel.2022.03.028 · Cited by 206
Leukocyte trafficking to the lungs and beyond: lessons from influenza for COVID-19
Alon, R., Sportiello, M., Kozlovski, S., Kumar, A., Reilly, E. C., Zarbock, A., Garbi, N., & Topham, D. J. (2021) · Nature Reviews Immunology · doi:10.1038/s41577-020-00470-2 · Cited by 197
Theoretical basis for stabilizing messenger RNA through secondary structure design
Wayment-Steele, H. K., Kim, D. S., Choe, C. A., Nicol, J. J., Wellington-Oguri, R., Watkins, A. M., Parra Sperberg, R. A., Huang, P.-S., Participants, E., & Das, R. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab764 · Cited by 197
Evolutionary and structural analyses of SARS-CoV-2 D614G spike protein mutation now documented worldwide
Isabel, S., Graña-Miraglia, L., Gutierrez, J. M., Bundalovic-Torma, C., Groves, H. E., Isabel, M. R., Eshaghi, A., Patel, S. N., Gubbay, J. B., Poutanen, T., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-70827-z · Cited by 204
Cross-Sectional Evaluation of Humoral Responses against SARS-CoV-2 Spike
Prévost, J., Gasser, R., Beaudoin-Bussières, G., Richard, J., Duerr, R., Laumaea, A., Anand, S. P., Goyette, G., Benlarbi, M., Ding, S., et al. (2020) · Cell Reports Medicine · doi:10.1016/j.xcrm.2020.100126 · Cited by 203
Molecular basis of receptor binding and antibody neutralization of Omicron
Qin, H., Han, W., Li, J., Xu, S., Wang, Y., Xu, C., Li, Z., Wang, Y., Zhang, C., Huang, Z. W., et al. (2022) · Nature · doi:10.1038/s41586-022-04581-9 · Cited by 198
Sars‐CoV‐2 Envelope and Membrane Proteins: Structural Differences Linked to Virus Characteristics?
Bianchi, M., Benvenuto, D., Giovanetti, M., Angeletti, S., Ciccozzi, M., & Pascarella, S. (2020) · BioMed Research International · doi:10.1155/2020/4389089 · Cited by 203
Molecular and Immunological Diagnostic Tests of COVID-19: Current Status and Challenges
Kiliç, T., Weissleder, R., & Lee, H. (2020) · iScience · doi:10.1016/j.isci.2020.101406 · Cited by 199
Inhibition of SARS-CoV-2 viral entry upon blocking N- and O-glycan elaboration
Yang, Q., Hughes, T. A., Kelkar, A., Yu, X., Cheng, K., Park, S., Huang, W., Lovell, J. F., & Neelamegham, S. (2020) · eLife · doi:10.7554/elife.61552 · Cited by 199
Cross-Neutralization of a SARS-CoV-2 Antibody to a Functionally Conserved Site Is Mediated by Avidity
Liu, H., Wu, N. C., Yuan, M., Bangaru, S., Torres, J. L., Caniels, T. G., van Schooten, J., Zhu, X., Lee, C.-C. D., Brouwer, P. J. M., et al. (2020) · Immunity · doi:10.1016/j.immuni.2020.10.023 · Cited by 201
Comprehensive Structural and Molecular Comparison of Spike Proteins of SARS-CoV-2, SARS-CoV and MERS-CoV, and Their Interactions with ACE2
Hatmal, M. M., Alshaer, W., Al-Hatamleh, M. A. I., Hatmal, M., Smadi, O., Taha, M. O., Oweida, A., Boer, J. C., Mohamud, R., & Plebanski, M. (2020) · Cells · doi:10.3390/cells9122638 · Cited by 205
DeepTracer for fast de novo cryo-EM protein structure modeling and special studies on CoV-related complexes
Pfab, J., Phan, N. M., & Si, D. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2017525118 · Cited by 198
Characterizations of SARS-CoV-2 mutational profile, spike protein stability and viral transmission
Laha, S., Chakraborty, J., Das, S., Manna, S. K., Biswas, S., & Chatterjee, R. (2020) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2020.104445 · Cited by 199
The outbreak of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): A review of the current global status
Bchetnia, M., Girard, C., Duchaine, C., & Laprise, C. (2020) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2020.07.011 · Cited by 205
Human angiotensin-converting enzyme 2 transgenic mice infected with SARS-CoV-2 develop severe and fatal respiratory disease
Golden, J. W., Cline, C. R., Zeng, X., Garrison, A. R., Carey, B. D., Mucker, E. M., White, L. E., Shamblin, J. D., Brocato, R. L., Liu, J., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.142032 · Cited by 200
Heterogeneous expression of the SARS-Coronavirus-2 receptor ACE2 in the human respiratory tract
Ortiz, M. E., Thurman, A. L., Pezzulo, A. A., Leidinger, M., Klesney‐Tait, J., Karp, P. H., Tan, P., Wohlford-Lenane, C., McCray, P. B., & Meyerholz, D. K. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.102976 · Cited by 199
Circulating ACE2-expressing extracellular vesicles block broad strains of SARS-CoV-2
El-Shennawy, L., Hoffmann, A. D., Dashzeveg, N. K., McAndrews, K. M., Mehl, P. J., Cornish, D., Yu, Z., Tokars, V. L., Nicolaescu, V. I., Τοματσίδου, Α., et al. (2022) · Nature Communications · doi:10.1038/s41467-021-27893-2 · Cited by 197
COVID-19 Control by Computer Vision Approaches: A Survey
Ulhaq, A., Born, J., Khan, A. A., Gomes, D. P. S., Chakraborty, S., & Paul, M. (2020) · IEEE Access · doi:10.1109/access.2020.3027685 · Cited by 203
Real-Time Conformational Dynamics of SARS-CoV-2 Spikes on Virus Particles
Lu, M., Uchil, P. D., Li, W., Zheng, D., Terry, D. S., Gorman, J., Shi, W., Zhang, B., Zhou, T., Ding, S., et al. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2020.11.001 · Cited by 198
One year update on the COVID-19 pandemic: Where are we now?
Mishra, S. K., & Tripathi, T. (2020) · Acta Tropica · doi:10.1016/j.actatropica.2020.105778 · Cited by 196
An update on SARS-CoV-2/COVID-19 with particular reference to its clinical pathology, pathogenesis, immunopathology and mitigation strategies
Dhama, K., Patel, S. K., Pathak, M., Yatoo, M. I., Tiwari, R., Malik, Y. S., Singh, R. P., Sah, R., Rabaan, A. A., Bonilla‐Aldana, D. K., et al. (2020) · Travel Medicine and Infectious Disease · doi:10.1016/j.tmaid.2020.101755 · Cited by 196
Cryo-EM analysis of the post-fusion structure of the SARS-CoV spike glycoprotein
Fan, X., Cao, D., Kong, L., & Zhang, X. (2020) · Nature Communications · doi:10.1038/s41467-020-17371-6 · Cited by 195
COVID-19 and SARS-CoV-2. Modeling the present, looking at the future
Estrada, E. (2020) · Physics Reports · doi:10.1016/j.physrep.2020.07.005 · Cited by 196
Metallodrug ranitidine bismuth citrate suppresses SARS-CoV-2 replication and relieves virus-associated pneumonia in Syrian hamsters
Yuan, S., Wang, R., Chan, J. F., Zhang, J., Cheng, T., Chik, K. K., Ye, Z., Wang, S., Lee, A. C.-Y., Jin, L., et al. (2020) · Nature Microbiology · doi:10.1038/s41564-020-00802-x · Cited by 196
SARS‐CoV‐2, the pandemic coronavirus: Molecular and structural insights
Kadam, S. B., Sukhramani, G. S., Bishnoi, P., Pable, A. A., & Barvkar, V. T. (2021) · Journal of Basic Microbiology · doi:10.1002/jobm.202000537 · Cited by 206
Considerable escape of SARS-CoV-2 Omicron to antibody neutralization
Planas, D., Saunders, N., Maes, P., Guivel‐Benhassine, F., Planchais, C., Buchrieser, J., Bolland, W., Porrot, F., Staropoli, I., Lemoine, F., et al. (2021) · Nature · doi:10.1038/d41586-021-03827-2 · Cited by 194
A human antibody reveals a conserved site on beta-coronavirus spike proteins and confers protection against SARS-CoV-2 infection
Zhou, P.-P., Yuan, M., Song, G., Beutler, N., Shaabani, N., Huang, D., He, W., Zhu, X., Callaghan, S., Yong, P., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abi9215 · Cited by 196
Review of COVID-19 mRNA Vaccines: BNT162b2 and mRNA-1273
Teo, S. P. (2022) · Journal of Pharmacy Practice · doi:10.1177/08971900211009650 · Cited by 191
Crystal Structure of the SARS-CoV-2 Non-structural Protein 9, Nsp9
Littler, D. R., Gully, B. S., Colson, R. N., & Rossjohn, J. (2020) · iScience · doi:10.1016/j.isci.2020.101258 · Cited by 191
Designing a multi-epitope vaccine against SARS-CoV-2: an immunoinformatics approach
Samad, A., Ahammad, F., Nain, Z., Alam, R., Imon, R. R., Hasan, M., & Rahman, M. S. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1792347 · Cited by 191
Medicinal Plants as Sources of Active Molecules Against COVID-19
Benarba, B., & Pandiella, A. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.01189 · Cited by 191
A novel rapid detection for SARS-CoV-2 spike 1 antigens using human angiotensin converting enzyme 2 (ACE2)
Lee, J.-H., Choi, M., Jung, Y., Lee, S. K., Lee, C., Kim, J., Kim, J.-W., Kim, N. H., Kim, B., & Kim, H. G. (2020) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2020.112715 · Cited by 195
Insights from nanotechnology in COVID-19 treatment
Tang, Z., Zhang, X., Shu, Y., Guo, M., Zhang, H., & Tao, W. (2020) · Nano Today · doi:10.1016/j.nantod.2020.101019 · Cited by 193
Rapid and unamplified identification of COVID-19 with morpholino-modified graphene field-effect transistor nanosensor
Li, J., Wu, D. C., Yu, Y., Li, T., Li, K., Xiao, M., Li, Y., Zhang, Z., & Zhang, G. (2021) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2021.113206 · Cited by 191
Ultrapotent antibodies against diverse and highly transmissible SARS-CoV-2 variants
Wang, L., Zhou, T., Zhang, Y., Yang, E. S., Schramm, C. A., Shi, W., Pegu, A., Oloniniyi, O. K., Henry, A. R., Darko, S. W., et al. (2021) · Science · doi:10.1126/science.abh1766 · Cited by 193
Self-citation
The Impact of Pre-existing Comorbidities and Therapeutic Interventions on COVID-19
Callender, L. A., Curran, M., Bates, S. M., Mairesse, M., Weigandt, J., & Betts, C. J. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01991 · Cited by 195
Molecular Mechanism of Evolution and Human Infection with SARS-CoV-2
He, J., Tao, H., Yan, Y., Huang, S., & Xiao, Y. (2020) · Viruses · doi:10.3390/v12040428 · Cited by 196
The Architecture of Inactivated SARS-CoV-2 with Postfusion Spikes Revealed by Cryo-EM and Cryo-ET
Liu, C., Mendonça, L., Yang, Y., Gao, Y., Shen, C., Liu, J., Ni, T., Ju, B., Liu, C., Tang, X., et al. (2020) · Structure · doi:10.1016/j.str.2020.10.001 · Cited by 195
SARS-CoV-2 tropism, entry, replication, and propagation: Considerations for drug discovery and development
Murgolo, N., Therien, A. G., Howell, B. J., Klein, D. J., Koeplinger, K. A., Lieberman, L. A., Adam, G. C., Flynn, J. A., McKenna, P. M., Swaminathan, G., et al. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009225 · Cited by 204
SARS-CoV-2 evolution in an immunocompromised host reveals shared neutralization escape mechanisms
Clark, S. A., Clark, L. E., Pan, J., Coscia, A., McKay, L. G. A., Shankar, S., Johnson, R. I., Brusic, V., Choudhary, M. C., Regan, J., et al. (2021) · Cell · doi:10.1016/j.cell.2021.03.027 · Cited by 193
SARS-CoV-2 envelope protein causes acute respiratory distress syndrome (ARDS)-like pathological damages and constitutes an antiviral target
Xia, B., Shen, X.-R., He, Y., Pan, X., Liu, F., Wang, Y., Yang, F., Fang, S., Wu, Y. L., Duan, Z., et al. (2021) · Cell Research · doi:10.1038/s41422-021-00519-4 · Cited by 197
Effects of a 2-Week 5000 IU versus 1000 IU Vitamin D3 Supplementation on Recovery of Symptoms in Patients with Mild to Moderate Covid-19: A Randomized Clinical Trial
Sabico, S., Enani, M. A., Sheshah, E., Aljohani, N. J., Aldisi, D. A., Alotaibi, N. H., Alshingetti, N. M., Alomar, S. Y., Alnaami, A. M., Amer, O. E., et al. (2021) · Nutrients · doi:10.3390/nu13072170 · Cited by 189
Cryo-EM and antisense targeting of the 28-kDa frameshift stimulation element from the SARS-CoV-2 RNA genome
Zhang, K., Zheludev, I. N., Hagey, R. J., Haslecker, R., Hou, Y. J., Kretsch, R., Pintilie, G. D., Rangan, R., Kladwang, W., Li, S., et al. (2021) · Nature Structural & Molecular Biology · doi:10.1038/s41594-021-00653-y · Cited by 189
Immune Evasion of SARS-CoV-2 Emerging Variants: What Have We Learnt So Far?
Lazarević, I., Pravica, V., Miljanovic, D., & Cupic, M. D. (2021) · Viruses · doi:10.3390/v13071192 · Cited by 193
The humoral response and antibodies against SARS-CoV-2 infection
Qi, H., Liu, B., Wang, X., & Zhang, L. (2022) · Nature Immunology · doi:10.1038/s41590-022-01248-5 · Cited by 195
Antibody signature induced by SARS-CoV-2 spike protein immunogens in rabbits
Ravichandran, S., Coyle, E. M., Klenow, L., Tang, J., Grubbs, G., Liu, S., Wang, T. T., Golding, H., & Khurana, S. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.abc3539 · Cited by 187
Obesity as a risk factor for COVID-19: an overview
Alberca, R. W., Oliveira, L. D. M., Branco, A. C. C. C., Pereira, N. Z., & Sato, M. N. (2020) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2020.1775546 · Cited by 191
AI-driven multiscale simulations illuminate mechanisms of SARS-CoV-2 spike dynamics
Casalino, L., Dommer, A. C., Gaieb, Z., de Barros, E. P., Sztain, T., Ahn, S.-H., Trifan, A., Brace, A., Bogetti, A. T., Clyde, A., et al. (2021) · The International Journal of High Performance Computing Applications · doi:10.1177/10943420211006452 · Cited by 193
A single dose of the SARS-CoV-2 vaccine BNT162b2 elicits Fc-mediated antibody effector functions and T cell responses
Tauzin, A., Nayrac, M., Benlarbi, M., Gong, S. Y., Gasser, R., Beaudoin-Bussières, G., Brassard, N., Laumaea, A., Vézina, D., Prévost, J., et al. (2021) · Cell Host & Microbe · doi:10.1016/j.chom.2021.06.001 · Cited by 193
Flexible Plasmonic Biosensors for Healthcare Monitoring: Progress and Prospects
Song, L., Chen, J., Xu, B. B., & Huang, Y. (2021) · ACS Nano · doi:10.1021/acsnano.1c07176 · Cited by 186
HLA class I–associated expansion of TRBV11-2 T cells in multisystem inflammatory syndrome in children
Porritt, R. A., Paschold, L., Rivas, M. N., Cheng, M. H., Yonker, L. M., Chandnani, H. K., Lopez, M., Simnica, D., Schultheiß, C., Santiskulvong, C., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci146614 · Cited by 194
Serologic Cross-Reactivity of SARS-CoV-2 with Endemic and Seasonal Betacoronaviruses
Hicks, J., Klumpp-Thomas, C. A., Kalish, H. R., Shunmugavel, A., Mehalko, J. L., Denson, J.-P., Snead, K., Drew, M. R., Corbett, K. S., Graham, B. S., et al. (2021) · Journal of Clinical Immunology · doi:10.1007/s10875-021-00997-6 · Cited by 192
Self-citation
Elicitation of broadly protective sarbecovirus immunity by receptor-binding domain nanoparticle vaccines
Walls, A. C., Miranda, M. C., Schäfer, A., Pham, M. N., Greaney, A., Arunachalam, P. S., Navarro, M.-J., Tortorici, M. A., Rogers, K., O’Connor, M. A., et al. (2021) · Cell · doi:10.1016/j.cell.2021.09.015 · Cited by 185
“SARS-CoV-2 infects host cells through the attachment of the viral transmembrane spike (S) glycoprotein to angiotensin-converting enzyme 2 (ACE2), followed by fusion of the viral and host membranes (Hoffmann et al., 2020; Lan et al., 2020; Letko et al., 2020; Shang et al., 2020; Walls et al., 2020a; Wang et al., 2020;…”
BackgroundSelf-citation
SARS-CoV-2 breakthrough infections elicit potent, broad, and durable neutralizing antibody responses
Walls, A. C., Sprouse, K. R., Bowen, J. E., Joshi, A., Franko, N., Navarro, M. J., Stewart, C., Cameroni, E., McCallum, M., Goecker, E. A., et al. (2022) · Cell · doi:10.1016/j.cell.2022.01.011 · Cited by 188
Alterations in microbiota of patients with COVID-19: potential mechanisms and therapeutic interventions
Wang, B., Zhang, L., Wang, Y., Dai, T., Qin, Z., Zhou, F., & Zhang, L. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00986-0 · Cited by 187
Pharmacological Inhibition of Acid Sphingomyelinase Prevents Uptake of SARS-CoV-2 by Epithelial Cells
Carpinteiro, A., Edwards, M. J., Hoffmann, M., Kochs, G., Gripp, B., Weigang, S., Adams, C., Carpinteiro, E., Gulbins, A., Keitsch, S., et al. (2020) · Cell Reports Medicine · doi:10.1016/j.xcrm.2020.100142 · Cited by 184
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19) – anatomic pathology perspective on current knowledge
Mohanty, S. K., Satapathy, A., Naidu, M. M., Mukhopadhyay, S., Sharma, S., Barton, L. M., Stroberg, E., Duval, E. J., Pradhan, D., Tzankov, A., et al. (2020) · Diagnostic Pathology · doi:10.1186/s13000-020-01017-8 · Cited by 185

Authors: Wrapp, D., Wang, N., Corbett, K. S., Goldsmith, J. A., Hsieh, C.-L., Abiona, O., Graham, B. S., & McLellan, J. S.
Affiliations: The University of Texas at Austin (US)
National Institutes of Health (US)
Corresponding author: McLellan, Jason S.
ORCID: Wrapp, Daniel
Wang, Nianshuang
Corbett, Kizzmekia S.
Goldsmith, Jory A.
Hsieh, Ching-Lin
Abiona, Olubukola
Graham, Barney S.
McLellan, Jason S.
Venue: Science
Publisher: American Association for the Advancement of Science (AAAS)
Published: 2020-03-13
Volume: 367
Issue: 6483
Pages: 1260-1263
ISSN: 0036-8075 (ISSN-L)
1095-9203
DOI: 10.1126/science.abb2507
PMC: PMC7164637
OpenAlex: W3007643904
Cited by: 8,897
References: 42
Citations by year: 2026: 220 · 2025: 378 · 2024: 570 · 2023: 894 · 2022: 1482 · 2021: 2591 · 2020: 2749
FWCI: 252.13
Type: journal article
Language: en
Open access: hybrid
doi.org
Licence: cc-by
Locations: Science (publishedVersion, cc-by)
bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion, cc-by)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
PubMed Central (submittedVersion, cc-by)
Funders: National Institute of Allergy and Infectious Diseases (R01-AI127521)
Topics: Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Structural Biology › Advanced Electron Microscopy Techniques and Applications
Life Sciences › Agricultural and Biological Sciences › Animal Science and Zoology › Animal Virus Infections Studies
Keywords: SARS-CoV-2, receptor binding domain, ACE2 binding affinity, antibody cross-reactivity
MeSH terms: Protein Domains, Betacoronavirus, Receptors, Coronavirus, Angiotensin-Converting Enzyme 2, SARS-CoV-2, Antibodies, Monoclonal, Antibodies, Viral, Cross Reactions, Image Processing, Computer-Assisted, Peptidyl-Dipeptidase A, Models, Molecular, Protein Binding, Protein Conformation, Receptors, Virus, Cryoelectron Microscopy, Severe acute respiratory syndrome-related coronavirus, Protein Multimerization, Spike Glycoprotein, Coronavirus

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks